SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 7, 2004
CORAUTUS GENETICS INC.
(Exact Name Of Registrant As Specified In Charter)
| | | | |
| Delaware | | 0-27264 | | 33-0687976 |
(State of Incorporation) | | (Commission File No.) | | (I.R.S. Employer Identification No.) |
75 Fifth Street, NW
Suite 313 Atlanta, Georgia 30308
(Address of principal executive offices, including zip code)
(404) 526-6200
(Registrant’s telephone number, including area code)
Item 5. Other Events
On July 7, 2004, Corautus Genetics Inc. issued a news release, attached hereto as Exhibit 99.1, announcing that it has raised $9.85 million in a private placement of common stock and warrants with institutional investors. The first tranche of the investment in the amount of $4.925 million has closed. The second $4.925 million tranche has been placed into escrow and will close upon the treatment of the first patient in the upcoming Phase IIb clinical trial for the treatment of severe cardiovascular disease.
| Item | 7. Financial Statements and Exhibits |
(c)
| | |
Exhibit
Number
| | Description
|
| 99.1 | | Press Release dated July 7, 2004. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | |
| | | Corautus Genetics Inc. |
| | |
Date: July 8, 2004 | | By: | | /s/ Jack W. Callicutt
|
| | | | | Jack W. Callicutt |
| | | | | Vice President - Finance and Administration, |
| | | | | Chief Accounting Officer and Assistant Secretary |
